Napolitano M, Potestio L, Hansel K, Marietti R, et al. Efficacy and safety of upadacitinib in adult patients affected by moderate to severe atopic dermatitis: a 16-week real-life dual-centre experience. Clin Exp Dermatol 2022 Nov 14:llac078. doi: 10.1093.
PMID: 36763761